المؤلفون: Slamon, D.J.¹ dslamon@mednet.ucla.edu, Neven, P.², Chia, S.³, Jerusalem, G.⁴, De Laurentiis, M.⁵, Im, S.⁶, Petrakova, K.⁷, Valeria Bianchi, G.⁸, Martín, M.⁹, Nusch, A.¹⁰, Sonke, G.S.¹¹, De la Cruz-Merino, L.¹², Beck, J.T.¹³, Ji, Y.¹⁴, Wang, C.¹⁵, Deore, U.¹⁴, Chakravartty, A.¹⁴, Zarate, J.P.¹⁴, Taran, T.¹⁵, Fasching, P.A.¹⁶

المصدر: Annals of Oncology. Aug2021, Vol. 32 Issue 8, p1015-1024. 10p.

مصطلحات موضوعية: *CHEMICAL inhibitors, *PROGRESSION-free survival, *HER2 protein, *BREAST cancer, *CYCLIN-dependent kinases, *FULVESTRANT

المؤلفون: Tutt, A.N.J.¹ (AUTHOR), Garber, J.² (AUTHOR), Gelber, R.D.² (AUTHOR), Phillips, K-A.³ (AUTHOR), Eisen, A.⁴ (AUTHOR), Johannsson, O.T.⁵ (AUTHOR), Rastogi, P.⁶ (AUTHOR), Cui, K.Y.⁷ (AUTHOR), Im, S-A.⁸ (AUTHOR), Yerushalmi, R.⁹ (AUTHOR), Brufsky, A.M.¹⁰ (AUTHOR), Taboada, M.¹¹ (AUTHOR), Rossi, G.¹² (AUTHOR), Yothers, G.¹³ (AUTHOR), Singer, C.¹⁴ (AUTHOR), Fein, L.E.¹⁵ (AUTHOR), Loman, N.¹⁶ (AUTHOR), Cameron, D.¹⁷ (AUTHOR), Campbell, C.¹⁸ (AUTHOR), Geyer, C.E.¹⁹ (AUTHOR)

المصدر: Annals of Oncology. May2022, Vol. 33 Issue 5, p566-568. 3p.

مصطلحات موضوعية: *CLINICAL trials, *OVERALL survival, *BREAST cancer, *OLAPARIB, *GERM cells, *METASTATIC breast cancer

مصطلحات جغرافية: OLYMPIA (Wash.)

المؤلفون: Robson, M E¹ (AUTHOR) robsonm@mskcc.org, Tung, N² (AUTHOR), Conte, P³ (AUTHOR), Im, S -A⁴ (AUTHOR), Senkus, E⁵ (AUTHOR), Xu, B⁶ (AUTHOR), Masuda, N⁷ (AUTHOR), Delaloge, S⁸ (AUTHOR), Li, W⁹ (AUTHOR), Armstrong, A¹⁰ (AUTHOR), Wu, W¹¹ (AUTHOR), Goessl, C¹¹ (AUTHOR), Runswick, S¹² (AUTHOR), Domchek, S M¹³ (AUTHOR)

المصدر: Annals of Oncology. Apr2019, Vol. 30 Issue 4, p558-566. 9p. 2 Charts, 4 Graphs.

مصطلحات موضوعية: *HORMONE receptor positive breast cancer, *TRIPLE-negative breast cancer, *METASTATIC breast cancer, *THERAPEUTICS, *EPIDERMAL growth factor receptors, *PHYSICIANS, *HORMONE receptors

المؤلفون: Huang, C-S.¹, Toi, M.², Im, Y-H.³, Iwata, H.⁴, Sohn, J.⁵, Wang, H-C.⁶, Masuda, N.⁷, Im, S-A.⁸, Lu, Y.⁹, Haddad, N.⁹, Sakaguchi, S.⁹, Hurt, K.⁹, Neven, P.¹⁰, Llombart-Cussac, A.¹¹, Sledge, G.¹²

المصدر: Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1258-S1259. 2p.

مصطلحات موضوعية: *BREAST cancer treatment, *HER2 protein, *OVERALL survival

المؤلفون: De Laurentiis, M.¹ (AUTHOR), Merino, L. de la Cruz² (AUTHOR), Hart, L.³ (AUTHOR), Bardia, A.⁴ (AUTHOR), Im, S-A.⁵ (AUTHOR), Sohn, J.⁶ (AUTHOR), Neven, P.⁷ (AUTHOR), Martin, M.⁸ (AUTHOR), Ji, Y.⁹ (AUTHOR), Yang, S.⁹ (AUTHOR), Hu, H.⁹ (AUTHOR), Lteif, A.⁹ (AUTHOR), Tripathy, D.¹⁰ (AUTHOR)

المصدر: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS378-S379. 2p.

مصطلحات موضوعية: *OVERALL survival, *BREAST cancer

المؤلفون: Emens, L.A.¹ (AUTHOR), Esteva, F.J.² (AUTHOR), Beresford, M.³ (AUTHOR), Saura, C.⁴ (AUTHOR), De Laurentiis, M.⁵ (AUTHOR), Kim, S.-B.⁶ (AUTHOR), Im, S.-A.⁷ (AUTHOR), Wang, Y.⁸ (AUTHOR), Mani, A.⁹ (AUTHOR), Shah, J.⁹ (AUTHOR), Liu, H.⁹ (AUTHOR), de Haas, S.¹⁰ (AUTHOR), Patre, M.¹¹ (AUTHOR), Loi, S.¹² (AUTHOR)

المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv104-v104. 1p.

مصطلحات موضوعية: *PACLITAXEL, *HER2 positive breast cancer, *OVERALL survival, *TUMOR-infiltrating immune cells, *ATEZOLIZUMAB, *PROGRAMMED death-ligand 1

الشركة/الكيان: NOVARTIS AG 001221845 NVS